Comparisons between normal and tumor tissues showed that ELFN1 expression was dysregulated in most tumor types and was associated with various clinical factors, underscoring its prognostic value in cancers such as CESC, COAD, KIRC, LIHC, LUAD, SKCM, and UVM. Here, ELFN1 is linked to cancer.